Access the full text.
Sign up today, get DeepDyve free for 14 days.
L. Brabin (2002)
Interactions of the female hormonal environment, susceptibility to viral infections, and disease progression.AIDS patient care and STDs, 16 5
T. Siraprapasiri, S. Thanprasertsuk, Amorn Rodklay, S. Srivanichakorn, P. Sawanpanyalert, Jirawan Temtanarak (1991)
SHORT COMMUNICATION: Risk factors for HIV among prostitutes in Chiangmai, ThailandAIDS, 5
A. Sousa, A. Chaves, M. Doroana, F. Antunes, R. Victorino (1999)
Kinetics of the changes of lymphocyte subsets defined by cytokine production at single cell level during highly active antiretroviral therapy for HIV-1 infection.Journal of immunology, 162 6
P. Marx, P. Marx, Alexander Spira, Alexander Spira, A. Gettie, P. Dailey, R. Veazey, A. Lackner, C. Mahoney, C. Miller, L. Claypool, D. Ho, N. Alexander (1996)
Progesterone implants enhance SIV vaginal transmission and early virus loadNature Medicine, 2
M. Carael, Van Ph, P. Lepage, S. Allen, F. Nsengumuremyi, C. VanGoethem, M. Ntahorutaba, D. Nzaramba, N. Clumeck (1988)
Human immunodeficiency virus transmission among heterosexual couples in Central Africa.AIDS, 2 3
R. Greenblatt, N. Ameli, R. Grant, P. Bacchetti, R. Taylor (2000)
Impact of the ovulatory cycle on virologic and immunologic markers in HIV-infected women.The Journal of infectious diseases, 181 1
C. Whitacre, S. Reingold, P. O'Looney, E. Blankenhorn, F. Brinley, E. Collier, P. Duquette, Howard Fox, B. Giesser, W. Gilmore, R. Lahita, J. Nelson, Carol Reiss, Peter Riskind, R. Voskuhl (1999)
A Gender Gap in AutoimmunityScience, 283
G. Gorochov, A. Neumann, A. Kereveur, C. Parizot, Taisheng Li, C. Katlama, M. Karmochkine, G. Raguin, B. Autran, P. Debré (1998)
Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapyNature Medicine, 4
T. Wilson, Yolanda Barrón, Mardge Cohen, J. Richardson, R. Greenblatt, H. Sacks, M. Young (2002)
Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 34 4
F. Sorvillo, P. Kerndt, S. Odem, M. Castillon, A. Carruth, R. Contreras (1999)
Use of protease inhibitors among persons with AIDS in Los Angeles County.AIDS care, 11 2
J. Simonse, F. Plummer, Elizabeth Ngugi, Charyln Black, J. Kreiss, MichaelN Gakinya, Peter Waiyaki, Lourdes DʼCosta, J. Ndinya-Achola, P. Piot, AllanR Ronald (1990)
HIV infection among lower socioeconomic strata prostitutes in Nairobi.AIDS, 4 2
M. Ruh, Y. Bi, L. Cox, D. Berk, A. Howlett, C. Bellone (1998)
Effect of environmental estrogens on IL-1β promoter activity in a macrophage cell lineEndocrine, 9
V. DeGruttola, L. Dix, R. D’Aquila, D. Holder, A. Phillips, M. Ait‐Khaled, J. Baxter, P. Clevenbergh, S. Hammer, R. Harrigan, D. Katzenstein, R. Lanier, Michael Miller, M. Para, S. Yerly, A. Zolopa, J. Murray, A. Patick, V. Miller, Steve Castillo, L. Pedneault, J. Mellors (2000)
The Relation between Baseline HIV Drug Resistance and Response to Antiretroviral Therapy: Re-Analysis of Retrospective and Prospective Studies Using a Standardized Data Analysis PlanAntiviral Therapy, 5
A. Phillips, Sophie Grabar, J. Tassie, Dominique Costagliola, Jens Lundgren, M. Egger (1999)
Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trials. EuroSIDA, the French Hospital Database on HIV and the Swiss HIV Cohort Study Groups.AIDS, 13 15
Stephen Smith, Stephen Smith, Gary Baskin, Preston Marx, Preston Marx (2000)
Estrogen protects against vaginal transmission of simian immunodeficiency virus.The Journal of infectious diseases, 182 3
A. Lazzarin, A. Saracco, M. Musicco, A. Nicolosi (1991)
Man-to-Woman Sexual Transmission of the Human Immunodeficiency Virus: Risk Factors Related to Sexual Behavior, Man’s Infectiousness, and Woman’s SusceptibilityJAMA Internal Medicine, 151
K. Anastos, Yolanda Barrón, P. Miotti, B. Weiser, M. Young, N. Hessol, R. Greenblatt, Mardge Cohen, M. Augenbraun, A. Levine, A. Muñoz (2002)
Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease.Archives of internal medicine, 162 17
J. Szekeres-Bartho, Gabriella Pár, L. Szereday, C. Smart, I. Achátz (1997)
Progesterone and Non‐specific Immunologic Mechanisms in PregnancyAmerican Journal of Reproductive Immunology, 38
A. Giovannetti, M. Pierdominici, F. Mazzetta, S. Salemi, M. Marziali, D. Kuonen, F. Iebba, E. Lusi, A. Cossarizza, F. Aiuti (2001)
T cell responses to highly active antiretroviral therapy defined by chemokine receptors expression, cytokine production, T cell receptor repertoire and anti‐HIV T‐lymphocyte activityClinical & Experimental Immunology, 124
O. Pontesilli, S. Kerkhof-Garde, D. Notermans, N. Foudraine, M. Roos, M. Klein, S. Danner, J. Lange, F. Miedema (1999)
Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy.The Journal of infectious diseases, 180 1
A. Lee, D. Mitra, J. Laurence (1997)
Interaction of pregnancy steroid hormones and zidovudine in inhibition of HIV type 1 replication in monocytoid and placental Hofbauer cells: implications for the prevention of maternal-fetal transmission of HIV.AIDS research and human retroviruses, 13 14
M. Clerici, G. Shearer (1994)
The Th1-Th2 hypothesis of HIV infection: new insights.Immunology today, 15 12
L. Jansson, R. Holmdahl (1998)
Estrogen-mediated immunosuppression in autoimmune diseasesInflammation Research, 47
(1983)
The central role of the propensity score in observation studies for causal effects
A. Lazzarin, A. Saracco, Massimo Musicco, Alfredo Nicolosi (1991)
Man-to-woman sexual transmission of the human immunodeficiency virus. Risk factors related to sexual behavior, man's infectiousness, and woman's susceptibility. Italian Study Group on HIV Heterosexual Transmission.Archives of internal medicine, 151 12
S. Barkan, S. Melnick, S. Preston‐Martin, K. Weber, L. Kalish, P. Miotti, M. Young, R. Greenblatt, H. Sacks, J. Feldman (1998)
The Women's Interagency HIV Study. WIHS Collaborative Study Group.Epidemiology, 9 2
James Mali, D. Hunter, B. Maggwa, P. Tukei (1995)
Contraceptive use and the risk of HIV infection in Nairobi, KenyaInternational Journal of Gynecology & Obstetrics, 48
M. Chiasson, Louise Berenson, Wenhui Li, Steven Schwartz, Tejinder Singh, Susan Forlenza, Benjamin Mojica, Margaret Hamburg (1999)
Declining HIV/AIDS mortality in New York City.Journal of acquired immune deficiency syndromes, 21 1
R. Gulick, J. Mellors, D. Havlir, J. Eron, C. González, D. McMahon, D. Richman, F. Valentine, L. Jonas, A. Meibohm, E. Emini, J. Chodakewitz (1997)
Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.The New England journal of medicine, 337 11
(1997)
Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. U.S. Department of Health and Human Services (DHHS).BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation
S. Romagnani, G. Prete, R. Manetti, A. Ravina, F. Annunziato, M. Carli, M. Mazzetti, M. Piccinni, M. D’Elios, P. Parronchi, S. Sampognaro, E. Maggi (1994)
Role of TH1/TH2 Cytokines in HIV InfectionImmunological Reviews, 140
Jorge Correale, M. Arias, W. Gilmore (1998)
Steroid hormone regulation of cytokine secretion by proteolipid protein-specific CD4+ T cell clones isolated from multiple sclerosis patients and normal control subjects.Journal of immunology, 161 7
M. Egger, B. Hirschel, P. Francioli, P. Sudre, Marc Wirz, M. Flepp, M. Rickenbach, R. Malinverni, P. Vernazza, M. Battegay (1997)
Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre studyBMJ, 315
R. Wilder (1996)
Adrenal and gonadal steroid hormone deficiency in the pathogenesis of rheumatoid arthritis.The Journal of rheumatology. Supplement, 44
L. Kirstein, R. Greenblatt, K. Anastos, A. Levine, A. French, H. Minkoff, S. Silver, S. Gange (2002)
Prevalence and Correlates of Highly Active Antiretroviral Therapy Switching in the Women's Interagency HIV StudyJAIDS Journal of Acquired Immune Deficiency Syndromes, 29
G. Lucas, R. Chaisson, R. Moore (1999)
Highly Active Antiretroviral Therapy in a Large Urban Clinic: Risk Factors for Virologic Failure and Adverse Drug ReactionsAnnals of Internal Medicine, 131
S. Allen, C. Lindan, A. Serufilira, P. Perre, A. Rundle, F. Nsengumuremyi, M. Carael, J. Schwalbe, S. Hulley (1991)
Human immunodeficiency virus infection in urban Rwanda. Demographic and behavioral correlates in a representative sample of childbearing women.JAMA, 266 12
Mohammed Kiddugavu, F. Makumbi, M. Wawer, D. Serwadda, N. Sewankambo, F. Wabwire-mangen, T. Lutalo, M. Meehan, &NA; Xianbin, R. Gray (2003)
Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, UgandaAIDS, 17
(1997)
Incidence and predictors of virologic failure to indinavir and/or ritonavir in an urban health clinic. (Abstract LB-02)
F. Plummer, J. Simonsen, D. Cameron, J. Ndinya-Achola, J. Kreiss, MichaelN Gakinya, P. Waiyaki, M. Cheang, P. Piot, A. Ronald, E. Ngugi (1991)
Cofactors in male-female sexual transmission of human immunodeficiency virus type 1.The Journal of infectious diseases, 163 2
M. Ostrowski, S. Justement, A. Catanzaro, Claire Hallahan, L. Ehler, S. Mizell, Princy Kumar, J. Mican, T. Chun, A. Fauci (1998)
Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals.Journal of immunology, 161 6
M. Joffe, P. Rosenbaum (1999)
Invited commentary: propensity scores.American journal of epidemiology, 150 4
R. Clark, R. Bessinger (1997)
Clinical manifestations and predictors of survival in older women infected with HIV.Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 15 5
R. Detels, A. Muñoz, G. McFarlane, L. Kingsley, J. Margolick, J. Giorgi, L. Schrager, J. Phair (1998)
Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators.JAMA, 280 17
R. Hogg, M. O'Shaughnessy, N. Gataric, B. Yip, K. Craib, M. Schechter, J. Montaner (1997)
Decline in deaths from AIDS due to new antiretroviralsThe Lancet, 349
C. Miller, J. Mcghee, M. Gardner (1993)
Mucosal immunity, HIV transmission, and AIDS.Laboratory investigation; a journal of technical methods and pathology, 68 2
S. Gange, Yolanda Barrón, R. Greenblatt, K. Anastos, H. Minkoff, Mary Young, A. Kovacs, M. Cohen, W. Meyer, A. Muñoz (2002)
Effectiveness of highly active antiretroviral therapy among HIV-1 infected womenJournal of Epidemiology and Community Health, 56
H. Cejtin, L. Jacobson, G. Springer, D. Watts, A. Levine, R. Greenblatt, K. Anastos, H. Minkoff, L. Massad, J. Schmidt (2003)
Effect of hormonal contraceptive use on plasma HIV-1-RNA levels among HIV-infected womenAIDS, 17
Donald Rubin (1997)
Estimating Causal Effects from Large Data Sets Using Propensity ScoresAnnals of Internal Medicine, 127
A. Fauci, J. Bartlett, E. Goosby, M. Smith, H. Kaiser, S. Chang, Jean Anderson, R. Armstead, A. Baker, David Barr, S. Bozzette, S. Cox, M. Delaney, F. Gordin, W. Greaves, M. Harrington, J. Henning, M. Hirsch, J. Jacobs, R. Marlink, C. Maxwell, J. Mellors, D. Nash, S. Perryman, R. Schooley, R. Sherer, S. Spector, G. Torres, P. Volberding, B. Brady, E. Daniels, D. Feigal, M. Feinberg, H. Gayle, T. Graydon, J. Kaplan, A. Macher, R. Martin, H. Masur, L. Mofenson, J. Murray, J. O'Neill, L. Pérez, R. Riseberg, S. Shekar, S. Stanley, J. Whitescarver (1998)
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000HIV Clinical Trials, 1
S. Barkan, S. Melnick, S. Preston‐Martin, K. Weber, L. Kalish, P. Miotti, M. Young, R. Greenblatt, H. Sacks, J. Feldman (1998)
The Women's Interagency HIV StudyEpidemiology, 9
(1997)
Update: trends in AIDS incidence, deaths, and prevalence--United States, 1996.MMWR. Morbidity and mortality weekly report, 46 8
The role of hormonal contraceptive use in the effectiveness of highly active antiretroviral therapy (HAART) was examined among participants in the Women's Interagency HIV Study who were followed from HAART initiation to 2001. Propensity score selection was used to match 77 hormonal contraceptive users with 77 nonusers on age, race, and pre-HAART CD4-positive T-lymphocyte (CD4+ cell) count and viral load. The authors compared hormonal contraceptive users and nonusers with regard to the CD4+ cell count and viral load responses to HAART upon initiation. Proportional hazards analyses were used to assess the effect of hormonal contraceptive use on times to increases in CD4+ cell count of 50 cells/mm3 and 100 cells/mm3 and achievement of an undetectable viral load. There were no statistically significant differences in CD4+ cell counts and log viral load responses by hormone use after HAART initiation, except in log viral load at the third visit after initiation (p = 0.047). Time-dependent hormonal contraceptive use was not a statistically significant predictor of achieving increases in CD4+ cell count of 50 cells/mm3 and 100 cells/mm3 or an undetectable viral load (p = 0.517, p = 0.751, and p = 0.218, respectively) after HAART initiation. In conclusion, the authors did not find substantial evidence that use of hormonal contraceptives strongly affected responses to HAART.
American Journal of Epidemiology – Oxford University Press
Published: May 1, 2005
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.